Additional Investigations Fail to Alter The Diagnosis of Irritable Bowel Syndrome in Subjects Fulfilling The Rome Criteria

Hamm, Lynne; Sorrells, Susan C.; Harding, Jacqueline; Northcutt, Allison R.; Heath, Amy; Kapke, Gordon F.; Hunt, Christine M.; Mangel, Allen W.

doi:10.1111/j.1572-0241.1999.01077.x

Cited by 96 publications

(4 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study was not designed to determine the safety of a diagnosis based on any of these particular criteria, as this question has been previously addressed by other studies [8, 9]. Vanner et al [9], in one of the only other studies of this nature, investigated the accuracy of the Rome I criteria in a clinical setting.…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies have shown that the Manning criteria are relatively sensitive, but lack specificity [7], thus the fear of overlooking serious disease remains. However, the newer Rome I criteria are more specific, and therefore, the chance of missing organic disease is very low [8]. Nevertheless, to date, no studies have attempted to establish how sensitive the current Rome II criteria are in actual clinical practice, and it has been suggested that the Rome criteria may be unnecessarily restrictive for this purpose [9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Diagnostic Criteria for Irritable Bowel Syndrome: Utility and Applicability in Clinical Practice

et al. 2004

View full text Add to dashboard Cite

Background/Aims: Symptom-based criteria have been introduced to aid the diagnosis of irritable bowel syndrome (IBS). Although they have been widely adopted and have proved useful for research purposes by ensuring homogeneity of study populations, there is little information about their utility in routine clinical practice. It was the aim of this study to assess the applicability of the Manning, Rome I and Rome II criteria in the clinical setting and to ascertain how often hospital specialists and general practitioners (GPs) use them. Methods: Hundred secondary-care IBS patients were assessed for their conformity to these criteria. Forty-eight hospital specialists and 68 GPs were asked about their knowledge and utilization of these criteria. Results: Seventy-three percent of IBS patients met Rome II diagnostic criteria with 82 and 94% meeting Rome I and Manning, respectively. Approximately 80% of GPs had no knowledge of any of the specific criteria, and only 4% had ever used them. The majority of specialists had knowledge of the criteria, with 70% having used them. Conclusion: The Rome II criteria are remarkably insensitive and if rigidly applied in the clinical situation would lead to much diagnostic uncertainty. The current lack of interest in them, especially amongst GPs, is unlikely to change unless they can be considerably improved.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Diagnostic Criteria for Irritable Bowel Syndrome: Utility and Applicability in Clinical Practice

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Contrary to what the literature dictates, it was observed that diagnostic procedures are formulated for patients who consult for IBS, a practice that, apart from generating a monetary cost to the user, does not support the diagnosis of the disease, since it has been demonstrated in several studies that the diagnosis of IBS is mainly clinical and that any other action aimed at confirming its presence, including colonoscopy, stool studies, and hematological studies, among others, has low efficacy [ 14 , 21 – 23 ]. However, it must be considered that the treating physician may request these diagnostic aids to rule out other pathologies that are generating the clinical manifestations.…”

Section: Discussionmentioning

confidence: 99%

Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study

Hernández-Velásquez,

Rodríguez-Martínez,

Montoya-Meneses

et al. 2023

Drugs - Real World Outcomes

View full text Add to dashboard Cite

Background Irritable bowel syndrome (IBS) is a functional disorder that leads to abdominal pain; its diagnosis is based on Rome IV criteria (recurrent abdominal pain at least 1 day per week in the last 3 months with more than two of the following: related to defecation, associated with a change in stool frequency and/or with a change in stool appearance). Objective To characterize an outpatient population diagnosed with IBS in Colombia during 2017–2018. Methods A cross-sectional study based on a review of clinical records of patients with a primary diagnosis of IBS. A representative sample of 380 individuals was recruited from a population of 38,182 people with a new diagnosis of IBS from a drug-claim database. Sociodemographic, clinical (symptoms, type of IBS, alarm features, etc.), treatment (pharmacological or not), and follow-up variables (for those with additional medical care at 3–12 months) were analyzed. The diagnosis and treatment used in the consultation were compared with clinical guidelines. Results Most of the 380 patients were women ( n = 238; 62.6%), and the mean age was 40.1 ± 15.0 years. None of the physicians recorded the Rome IV criteria in the medical records. Unclassified IBS was the most prevalent subtype ( n = 311; 81.8%), and the main symptom was abdominal pain ( n = 327; 86.1%). Only 73 patients (19.2%) had follow-up data. The most frequently used drugs were aluminum hydroxide ( n = 203; 53.4%) and hyoscine N -butyl bromide ( n = 200; 52.6%). Regarding drugs included in the clinical practice guidelines, 19 people received loperamide (5.0%), 3 received trimebutine (0.8%), and 1 received sertraline (0.3%). Conclusions The patients were diagnosed without clearly established criteria, and they were treated symptomatically with little follow-up.

show abstract

“…63 However, a study conducted in the United States reported that the prevalence of parasitic infections among patients with suspected IBS is very low (2%). 64 Consequently, the ACG does not recommend routine stool testing for enteric pathogens in all patients with IBS. 22 In LMICs, the environment is often characterized as nonsterile, exposing a significant portion of the population to both acute and chronic gastrointestinal infections.…”

Section: Determination Of Relevant Diagnostic Testingmentioning

confidence: 99%

Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective

Hidayat,

Waskito,

Sugihartono

et al. 2024

Intest Res

View full text Add to dashboard Cite

show abstract

Additional Investigations Fail to Alter The Diagnosis of Irritable Bowel Syndrome in Subjects Fulfilling The Rome Criteria

Cited by 96 publications

References 20 publications

Diagnostic Criteria for Irritable Bowel Syndrome: Utility and Applicability in Clinical Practice

Diagnostic Criteria for Irritable Bowel Syndrome: Utility and Applicability in Clinical Practice

Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study

Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective

Contact Info

Product

Resources

About